Cencora, Inc. (COR) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Walgreens Boots Alliance Holdings LLC avec 52,854,867 actions. Parmi les autres détenteurs notables Walgreens Boots Alliance, Inc. et STOLL ROGER G PHD.
Au cours des 12 derniers mois, les initiés ont effectué 90 transactions sur COR l'action — 34 achats (d'une valeur de $2.56M) et 8 ventes (d'une valeur de $6.23M). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
COR Participations des Initiés
Principal Actionnaire
Walgreens Boots Alliance Holdings LLC
52,854,867 actions
Achats (12 mois)
34
$2.56M valeur
Ventes (12 mois)
8
$6.23M valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Walgreens Boots Alliance Holdings Llc |
Director |
52,854,867 |
2022-05-13 |
|
| 2 |
Walgreens Boots Alliance, Inc. |
10 Percent Owner |
19,980,000 |
2024-08-05 |
|
| 3 |
Stoll Roger G Phd |
Executive Chairman |
3,083,334 |
2012-08-14 |
|
| 4 |
Messinger Maria S |
Chief Financial Officer |
380,000 |
2009-08-24 |
|
| 5 |
Johnson Steven Andrew |
VP, Preclinical Development |
262,000 |
2009-08-24 |
|
| 6 |
Coleman James H |
Sr. VP, Business Development |
200,397 |
2007-11-19 |
|
| 7 |
Mansbach Harry H |
Chief Medical Officer |
100,000 |
2005-12-05 |
|
| 8 |
Chou John G. |
Executive Vice President |
81,367 |
2021-12-21 |
|
| 9 |
Mauch Robert P. |
President & CEO |
65,393 |
2026-02-20 |
|
| 10 |
Collis Steven H |
Executive Chairman |
58,699 |
2025-09-18 |
|
| 11 |
Breuil Robert S |
Chief Financial Officer |
50,000 |
2015-12-10 |
|
| 12 |
Tran Pierre V |
Chief Medical Officer |
50,000 |
2009-08-24 |
|
| 13 |
Singh Parminder |
CTO & Vice President, R&d |
45,000 |
2015-12-10 |
|
| 14 |
Rockwood Robert K. |
SVP, General Management |
39,868 |
2014-04-10 |
|
| 15 |
Cotman Carl W |
Director |
30,000 |
2012-08-07 |
|
| 16 |
Casamento Charles J |
Director |
30,000 |
2010-03-04 |
|
| 17 |
Drake Peter F |
Director |
30,000 |
2012-08-07 |
|
| 18 |
Allnutt Robert |
Director |
30,000 |
2012-08-07 |
|
| 19 |
Gochnauer Richard W |
Director |
28,762 |
2024-03-13 |
|
| 20 |
Staple Peter D |
President & CEO |
28,378 |
2016-05-17 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-04-01 |
Krikorian Lazarus |
SVP & Chief Accounting Officer |
Attribution de RSU |
3,936 |
- |
- |
| 2026-03-11 |
Campbell Elizabeth S |
Executive Vice President |
Exercice d'Options (Vente) |
12,623 |
- |
- |
| 2026-03-11 |
Battaglia Silvana |
Executive Vice President |
Exercice d'Options (Vente) |
8,415 |
- |
- |
| 2026-03-11 |
Cleary James F |
Chief Financial Officer |
Exercice d'Options (Vente) |
12,623 |
- |
- |
| 2026-03-05 |
Baumann Werner |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Miller Redonda |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Tyler Lauren M |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Tyler Lauren M |
Director |
Attribution de RSU |
84 |
$359.22 |
$30.17K |
| 2026-03-05 |
Clyburn Frank |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Nally Dennis M |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Nally Dennis M |
Director |
Attribution de RSU |
98 |
$359.22 |
$35.2K |
| 2026-03-05 |
Kim Lorence H. |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Cooper Ellen |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Cooper Ellen |
Director |
Attribution de RSU |
69 |
$359.22 |
$24.79K |
| 2026-03-05 |
Ryerkerk Lori |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Greenberg Lon R |
Director |
Attribution de RSU |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Durcan Dermot Mark |
Director |
Attribution de RSU |
905 |
$359.28 |
$325.15K |
| 2026-02-20 |
Mauch Robert P. |
President & CEO |
Exercice d'Options (Vente) |
3,762 |
$86.09 |
$323.87K |
| 2026-02-18 |
Mauch Robert P. |
President & CEO |
Vente Informative |
1,333 |
$359.46 |
$479.16K |
| 2026-01-20 |
Cooper Ellen |
Director |
Inconnu |
- |
- |
- |
| 2026-01-20 |
Mauch Robert P. |
President & CEO |
Exercice d'Options (Vente) |
3,763 |
$86.09 |
$323.96K |
| 2025-09-30 |
Clyburn Frank |
Director |
Inconnu |
- |
- |
- |
| 2025-12-31 |
Campbell Elizabeth S |
Executive Vice President |
Attribution de RSU |
34 |
$287.09 |
$9.76K |
| 2025-12-31 |
Battaglia Silvana |
Executive Vice President |
Attribution de RSU |
27 |
$287.09 |
$7.75K |
| 2025-12-19 |
Campbell Elizabeth S |
Executive Vice President |
Vente Informative |
3,351 |
$342.10 |
$1.15M |
Les autres consultent aussi